http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003024415-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f4c2477bdea308bc9dec3feded37457
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J1-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
filingDate 2002-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb80effa78a77ebb4c0e067afe686cb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6625c4fd69438e61ae711dcaa3f6ae80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2124609c041fe2b1f26607addf6922ba
publicationDate 2003-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2003024415-A
titleOfInvention Injection container
abstract [PROBLEMS] Isosorbide dinitrate, which is useful as a prophylactic / therapeutic agent for ischemic heart disease, is adsorbed on polyethylene, polypropylene, etc., which are currently used as materials for syringes and infusion bags, and has a low content. It is known that it will decrease. Therefore, an object of the present invention is to provide a novel injection container which does not adsorb isosorbide dinitrate. The above problem can be solved by manufacturing an injection container using a material such as a cycloolefin copolymer or a cycloolefin polymer. Further, since the drug content does not decrease even when stored for a long period of time, it has become possible to produce a prefilled syringe preparation.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010503493-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9962498-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9956203-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008001496-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8668971-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2311430-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9050243-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7003493-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009066752-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005525952-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8603638-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018043492-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1830808-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9234118-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8816022-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017275295-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019037633-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4732751-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8029885-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014065345-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014083292-A
priorityDate 2001-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27661
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6883
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414557
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546412
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414558
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66623903
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534614
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID943
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226571450
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62989
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10114
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12597

Total number of triples: 51.